CTIS2023-503644-13-00进行中（未招募）1 期
Topical tacrolimus for the amelioration of breast cancer-related lymphedema: a randomized, double-blind, placebo-controlled phase II/III trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
入选标准
- •Age > 18 years, BCRL ISL stage I or II, Pitting edema, Postmenopausal or use of Contraceptive drugs, Healthy opposite arm, L-Dex score>10, Lymphedema volume >10% of healthy arm, Comprehension of Danish, Female
排除标准
- •Pregnant, breast-feeding, or aiming to conceive within the next year, Bilateral breast cancer, Contralateral lymphadenectomy, Allergy to tacrolimus, macrolides, or iodine, Pacemaker implant, Known kidney or liver disease, Defect skin-barrier on the affected arm, Diagnosed immunodeficiency or treated with immunosuppressive medicine, No previous surgical treatment for lymphedema
研究者
相似试验
Enrolling By Invitation
2 期
Topical Tacrolimus for Breast Cancer-related LymphedemaLymphedemaNCT06306274Odense University Hospital80
进行中（未招募）
1 期
Tacrolimus as Treatment of Breast Cancer-Related LymphedemaymphedemaMedDRA version: 20.0Level: LLTClassification code 10025233Term: LymphedemaSystem Organ Class: 100000004866EUCTR2020-000877-25-DKOdense University Hospital20
已完成
1 期
Tacrolimus as Treatment of Breast Cancer-Related LymphedemaBreast Cancer LymphedemaNCT04541290Odense University Hospital20
已完成
1 期
Safety and efficacy of topical tacrolimus therapy for refractory pouchitispouchitisJPRN-UMIN000006658Department of lower gastroenterological surgery, Hyogo college of Medicine10
招募中
2 期
Treatment of Superficial Strawberry Birthmarks with Topical TimololInfantile HaemangiomaSkin - Dermatological conditionsACTRN12619001370190Gillies McIndoe Research Institute50